"Anaphylatoxins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum peptides derived from certain cleaved COMPLEMENT PROTEINS during COMPLEMENT ACTIVATION. They induce smooth MUSCLE CONTRACTION; mast cell HISTAMINE RELEASE; PLATELET AGGREGATION; and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from the strongest to the weakest is C5a, C3a, C4a, and C5a des-arginine.
Descriptor ID |
D000706
|
MeSH Number(s) |
D12.776.124.486.274.024
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anaphylatoxins".
Below are MeSH descriptors whose meaning is more specific than "Anaphylatoxins".
This graph shows the total number of publications written about "Anaphylatoxins" by people in this website by year, and whether "Anaphylatoxins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Anaphylatoxins" by people in Profiles.
-
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Front Immunol. 2021; 12:668725.
-
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Front Immunol. 2021; 12:684014.
-
Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients. Crit Care. 2021 02 08; 25(1):51.
-
Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol. 2006 Nov; 126(11):2422-9.